| Financial Year |
March 31 2023 |
| Monetary Funds |
477,910,158.70 |
| Held-for-trading Financial Assets |
169,322,400.00 |
| Notes Receivable |
4,500,000.00 |
| Accounts Receivable |
8,991,376.22 |
| Advances to Suppliers |
10,120,619.67 |
| Other Receivables |
15,892,069.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
52,358,797.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,704,624.29 |
| Total Current Assets |
772,800,045.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
291,709,937.73 |
| Investment Properties |
290,438,853.05 |
| Fixed Assetes |
76,863,619.77 |
| Under-construction Projects |
10,669,984.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
382,726,711.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
54,940,602.71 |
| Other Non-Current Assets |
17,537,361.53 |
| Sub-Total of Non-Current Assets |
1,155,887,070.72 |
| Total Assets |
1,928,687,116.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
40,032,795.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,238,630.30 |
| Taxes Payable |
8,058,520.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,428,112.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
248,128.43 |
| Sub-Total of Current Liabilities |
233,069,412.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
31,735,828.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,146,736.03 |
| Deferred Income Tax Liabilities |
29,265,600.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,693,762.02 |
| Total Liabilities |
301,763,174.34 |
| Paid-In Capital(Or Share Stock) |
142,436,840.00 |
| Capital Surplus |
541,278,547.50 |
| Surplus Reserve |
71,218,420.00 |
| LESS:Treasury Stock |
73,631,259.00 |
| Undistributed Profits |
609,959,823.03 |
| Minority Stockholder's Interest |
336,318,480.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,290,605,461.21 |
| Owner's Equity（Stockholder's Equity） |
1,626,923,942.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,928,687,116.42 |
